Streetbeat News

Analyst Ratings

MTDR

Truist Securities has maintained a Buy rating on Matador Resources but lowered the price target from $86 to $75.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:54 pm

IIIV

DA Davidson analyst Peter Heckmann maintains a Buy rating on i3 Verticals (NASDAQ:IIIV) with a $32 price target.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:54 pm

MRO

Truist Securities has maintained a Buy rating on Marathon Oil but lowered the price target from $35 to $27.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:51 pm

SOUN

DA Davidson analyst Gil Luria has reiterated a Buy rating for SoundHound AI with a maintained price target of $9.5.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:51 pm

QTWO

DA Davidson analyst Peter Heckmann maintains a Neutral rating on Q2 Holdings (NYSE:QTWO) with a price target of $76.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:47 pm

FUTU

Futu Holdings (NASDAQ:FUTU) has seen a surge in options activity, with a majority of trades being bullish. Significant investors are targeting a price range of $65 to $120. The stock is currently trading at $102.23, up 19.32%, but RSI indicators suggest it may be overbought. An analyst from B of A Securities maintains a Buy rating with a target price of $90.

Portfolio Pulse from Benzinga Insights

September 30, 2024 | 2:45 pm

VFS

Cantor Fitzgerald analyst Andres Sheppard has reiterated an Overweight rating on VinFast Auto (NASDAQ:VFS) and maintained a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:45 pm

MGY

Truist Securities has maintained a Buy rating on Magnolia Oil & Gas but lowered the price target from $35 to $31.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:37 pm

KRP

Truist Securities has maintained a Buy rating on Kimbell Royalty Partners but lowered the price target from $23 to $21.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:35 pm

INSP

Truist Securities has reiterated its Buy rating on Inspire Medical Systems and increased the price target from $217 to $240, indicating confidence in the company's future performance.

Portfolio Pulse from Benzinga Newsdesk

September 30, 2024 | 2:33 pm